Sponsor dell'anno
Ultimo aggiornamento: Best view 1024 x 768
Pubblicazioni
Elenco completo
TITOLO AUTORI EDITORE ANNO DOSSIER PAGINE LINGUA
Is APD a promising drug in the treatment of severe osteogenesis imperfecta? Huaux JP, Lokietek W, J Pediatr Orthoped 1988 8 71-72 en
Severe osteogenesis imperfecta: effect of one year of pamidronate (APD) treatment in children under two years of age Plotkin H, Rauch F, Lanoue G, Travers R, Glorieux FH, Bone 1988 23 s192 en
Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas Vallar L, Spada A, Giannattasio G, Nature 1987 330 566-567 en
Progression from gonadotropin-indipendent to gonadotropin-dependent puberty in a girl Pasquino AM, Tebaldi L, Cices C, Maciocci M, Boscherini B, Acta Paediatr (Scand) 1987 76 841-843 en
Fibrous Dysplasia Stephenson RB, London MD, Hankin FM, Kaufer H, J Bone Joint Surg 1987 69-A 400-409 en
Multiple osteotomies with Zickel nail fixation for polyostotic fibrous dysplasia involving the proximal part of the femur Freeman BH, Bray EW, Mayer LC, J Bone Joint Surg 1987 69-A 691-698 en
The McCune-Albright syndrome: a lethal gene surviving by mosaicism Happle R, Clin Genet 1986 29 321-324 en
The McCune-Albright syndrome Mauras N., Blizzard RM, Acta Endocirnol (Copenh) 1986 279 207-217 en
Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone Feuillan PP, Foster CM, Pescovitz OH, Hench KD, Shawker T, Dwyer A, Malley JD, Barnes K, Loriaux DL, Cutler GB Jr, N Engl J Med 1986 315 1115-1119 en
Direct measurement of TP/GFR: a simple and reliable parameter of renal phophate handling Stark H, Eisenstein B, Tieder M, Rachmel A, Alpert G, Nephron 1986 44 125-128 en
Fibrodysplasia ossificans. Presentation of a case of exceptional severity Cottafava F, Nieri S, Racugno A, Corciulo P, Prestandrea C, Brida di Prio S, Villa Venzano G, Pinelli G, Minerva Pediatr 1986 38 53-58 en
Testolactone treatment of precociuous puberty in McCune-Albright syndrome Foster CM, Pescovitz OH, Comite F, Feuillan P, Shawker T, Loriaux DL, Cutler GB Jr, Acta Endocrinol (Copenh) 1985 109 254-257 en
Prolonged activation of hypothalamic-pituitary-ovarian axis during early infancy in female patients with saltlosing 21-hydoxylase deficiency Maesaka H, Suwa S, Tachibana K, Katsumata N, Pediatr Res 1985 19 1258-1262 en
Characteristics and bisphosphonate treatment of a patient with juvenile osteoporosis Hoekman K, Papapoulos SE, Peters AC, Bijvoet OL, Journal of Pediatric Endocrinology & Metabolism (JPEM) 1985 61 952-956 en
Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome Foster CM, Ross Jl, Shawker T, Pescovitz OH, Loriaux DL, Cutler GB Jr, J Clin Endocrinol Metab 1984 5 1161-1165 en
Disodium etidronate in hypercalcaemia due to immobilistation Hagg E, Eklund M, Torring O, Br Med J 1984 288 607-608 en
Regression of bone lesions in Gaucher's disease during treatment with aminohydroxyproylidene bisphosphonate [Letter] Harinck HI, Bijvoet OL, van der Meer JW, Jones B, Onvlee GJ, Lancet 1984 ii 513 en
Incidence of ovulation in the years after the menarche Metcalf MG, Skidmore DS, Lowry GF, Mackenzie JA, J Endocrinol 1982 97 213-219 en
Immunoreactivity of standard and reference preparation used in the radioimmunoassay of follicle-stimulating and luteinizing hormones in serum Rosenberg E, J Clin Endocrinol Metab 1979 48 163-166 en
Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma Metzger AL, Singer FR, Bluestone R, Pearson CM, N Engl J Med 1974 291 1294-1296 en
Righe 20 di 186 Pagine: [ 1 ] [ 2 ] [ 3 ] [ 4 ] [ 5 ] [ 6 ] [ 7 ] [ 8 ] [ 9 ] [ 10 ]
